↓ Skip to main content

ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development

Overview of attention for article published in Journal of Hematology & Oncology, November 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
1 news outlet
blogs
3 blogs
policy
1 policy source
twitter
2 X users
patent
3 patents
wikipedia
1 Wikipedia page

Readers on

mendeley
320 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development
Published in
Journal of Hematology & Oncology, November 2015
DOI 10.1186/s13045-015-0224-3
Pubmed ID
Authors

Shundong Cang, Chaitanya Iragavarapu, John Savooji, Yongping Song, Delong Liu

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 320 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
India 1 <1%
Unknown 318 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 70 22%
Student > Master 45 14%
Researcher 39 12%
Student > Bachelor 37 12%
Student > Doctoral Student 18 6%
Other 40 13%
Unknown 71 22%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 86 27%
Agricultural and Biological Sciences 40 13%
Medicine and Dentistry 38 12%
Pharmacology, Toxicology and Pharmaceutical Science 24 8%
Chemistry 20 6%
Other 33 10%
Unknown 79 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 38. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 May 2024.
All research outputs
#1,092,788
of 25,846,867 outputs
Outputs from Journal of Hematology & Oncology
#55
of 1,310 outputs
Outputs of similar age
#17,702
of 395,259 outputs
Outputs of similar age from Journal of Hematology & Oncology
#1
of 23 outputs
Altmetric has tracked 25,846,867 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,310 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.4. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 395,259 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.